COVID-19 Omicron (B.1.1.529) Variant
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.
Resources on updated COVID-19 boosters for everyone 6 months and older
On December 9, 2022, the CDC (following authorization by the FDA), CDC expanded the use of updated (bivalent) COVID-19 booster vaccines for children ages 6 months through 5 years. Learn more here.
Annual Reports
The Association of Immunization Managers (AIM) and its members are dedicated to establishing a nation free of vaccine-preventable disease. AIM members are the leaders of state, local, and territorial immunization…
AIM: Fertility, Pregnancy, and COVID-19 Vaccines Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
COVID-19 Booster Dose Update (AIM)
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide updated information on COVID-19 vaccine booster doses.
2025 Bull’s-Eye Award Winner Minnesota: Becoming a Vaccine Advocate Training
The Minnesota Department of Health (MDH) created and piloted a vaccine advocate training, modeled on Voices for Vaccines’ Trusted Messenger training.
Illinois: Under 5 COVID-19 Campaign and Podcast
A podcast was created in Illinois to help physicians talk in a casual setting about COVID-19 vaccination and reach target demographics.
Seattle, Washington: Public Schools COVID-19 Vaccination Program
Seattle Public Schools hosted COVID-19 vaccination clinics at schools to easily reach target demographics.
2025 Immunization Champion Award Winners
Announcing the 2025 Immunization Champions award winners! Please read through to learn more about the 2025 Champions from various jurisdictions.
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.